Investor Relations :: Cabaletta Bio, Inc. (CABA)
https://www.cabalettabio.com/investors
WEBDec 31, 2023 · Cabaletta Bio is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies for autoimmune diseases. Our proprietary Cabaletta Approach to B cell Ablation (CABA ® ) platform is designed to provide durable, potentially curative, responses with one-time administration, with the possibility …
DA: 91 PA: 4 MOZ Rank: 38